These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Experience in cancer of the uterine cervix treated with surgery--an analysis of 820 cases].
    Author: Tan DC.
    Journal: Zhonghua Zhong Liu Za Zhi; 1990 Nov; 12(6):447-9. PubMed ID: 2076643.
    Abstract:
    From 1962 to November 1985, 1000 cases of cervical cancer were treated surgically, of whom 820 (37 Stage 0, 371 Stage I, 399 Stage II, 10 Stage III and 3 Stage IV lesions) had been operated before 1982. In the 820 cases, squamous cell cancer comprised 90.5%, adenocarcinoma 8.8% and adenoacanthoma or adenosquamous cancer 0.7%. Pelvic lymph node metastasis rate was 8.9% and 24.1% in Stages I and II. The obturator region was the most vulnerable to metastasis. The 5-year survival rate was 86.7% in 173 cases of infiltrative cancer treated during 1978-1982. The 10-year survival rate was 85.25% (520/610) in the infiltrative cancer, 95.9% in Stage I and 75.3% in Stage II. Two cases with Stage IV without pelvic lymph node metastasis treated with surgery have survived for over 10 years. All thirty-seven cases of cervical cancer in situ treated with surgery are still alive. Pelvic lymph node metastasis is the major factor influencing operation and survival.
    [Abstract] [Full Text] [Related] [New Search]